Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-088290
Filing Date
2022-03-29
Accepted
2022-03-29 17:28:44
Documents
5
Effectiveness Date
2022-03-29

Document Format Files

Seq Description Document Type Size
1 S-8 d341159ds8.htm S-8 33182
2 EX-5.1 d341159dex51.htm EX-5.1 6843
3 EX-23.1 d341159dex231.htm EX-23.1 1810
4 EX-FILING FEES d341159dexfilingfees.htm EX-FILING FEES 19135
5 GRAPHIC g341159g0329193957192.jpg GRAPHIC 2751
  Complete submission text file 0001193125-22-088290.txt   66053
Mailing Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494 617-916-5445
Candel Therapeutics, Inc. (Filer) CIK: 0001841387 (see all company filings)

EIN.: 522214851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263961 | Film No.: 22782190
SIC: 2836 Biological Products, (No Diagnostic Substances)